Th1 Cytokine-Secreting Recombinant Bacillus Calmette-Guérin: Prospective Use in Immunotherapy of Bladder Cancer
None
Saved in:
| Main Authors: | Luo, Yi, Henning, Jonathan, O’Donnell, Michael A. |
|---|---|
| Format: | Electronic Book Chapter |
| Language: | English |
| Published: |
IntechOpen
2011
|
| Subjects: | |
| Online Access: | https://www.intechopen.com/chapters/24577 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pneumonitis secondary to intravesical Bacillus-Calmette-Guérin (BCG) immunotherapy
by: Komeil Alattar, MBBS, PGCert, et al.
Published: (2025-09-01) -
Rates and Risk Factors of Bacteriuria in Patients with Bladder Cancer Who Underwent Treatment with Bacillus Calmette-Guérin
by: Seong Jong Eun, et al.
Published: (2020-08-01) -
Successful complex endovascular treatment of a contained rupture of a thoracoabdominal aortic aneurysm caused by Mycobacterium bovis after intravesical Bacillus Calmette-Guerin immunotherapy for bladder cancer
by: Laina Passos, et al.
Published: (2025-10-01) -
Performance of the Sysmex UF-1000i System in Screening for Significant Bacteriuria in Patients with Bladder Cancer Who Received Bacillus Calmette-Guérin Treatment
by: Tae Hee Kim, et al.
Published: (2020-08-01) -
The role of Uro-Vaxom in reducing infectious adverse effects and improving outcomes in bacillus Calmette-Guérin therapy for non-muscle-invasive bladder cancer
by: Sookyung Cho, et al.
Published: (2025-07-01)


